The role of screening and monitoring for bleomycin pulmonary toxicity

被引：21

作者：

Shippee, Brittney M. ^{[1
]}

Bates, Jill S. ^{[2
]}

Richards, Kristy L. ^{[3
,4
]}

机构：

[1] UAB Med, Dept Pharm, JT 1728-619 19th St South, Birmingham, AL 35249 USA

[2] Univ N Carolina, Med Ctr, Dept Pharm, Chapel Hill, NC USA

[3] Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

[4] Univ N Carolina, UNC Sch Med, Div Hematol Oncol, Chapel Hill, NC USA

来源：

JOURNAL OF ONCOLOGY PHARMACY PRACTICE | 2016年 / 22卷 / 02期

关键词：

Bleomycin; pulmonary toxicity; monitoring; risk factors; CANCER; CHEMOTHERAPY;

D O I：

10.1177/1078155215574294

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Bleomycin-induced pulmonary toxicity can have a significant impact on patient outcomes. However, no guidelines for ideal screening and monitoring are available. This paper reviews the literature to identify the best way to monitor and reduce patient risk for bleomycin pulmonary toxicity. We have created evidence-based guidelines to help healthcare professionals identify patient risk factors and provide appropriate assessment and monitoring for patients receiving bleomycin therapy.

引用

页码：308 / 312

页数：5

共 50 条

[41] BLEOMYCIN PULMONARY TOXICITY - ITS RELATIONSHIP TO RENAL DYSFUNCTION
DALGLEISH, AG
WOODS, RL
LEVI, JA
MEDICAL AND PEDIATRIC ONCOLOGY, 1983, 11 (03): : 212 - 212
[42] PULMONARY-FUNCTION TESTS AND PREVENTION OF BLEOMYCIN TOXICITY
LAMONTE, CS
CVITKOVIC, E
GOLBEY, RB
KRAKOFF, I
GORELICK, K
CHEST, 1978, 74 (03) : 341 - 342
[43] BIOCHEMICAL AND MORPHOLOGICAL ASSESSMENTS OF BLEOMYCIN PULMONARY TOXICITY IN RATS
TOM, WM
MONTGOMERY, MR
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1980, 53 (01) : 64 - 74
[44] BLEOMYCIN PULMONARY TOXICITY - ITS RELATIONSHIP TO RENAL DYSFUNCTION
DALGLEISH, AG
WOODS, RL
LEVI, JA
MEDICAL AND PEDIATRIC ONCOLOGY, 1984, 12 (05): : 313 - 317
[45] Imatinib Treatment for Bleomycin-Induced Pulmonary Toxicity
Aykac, Nilufer
Tecimer, Coskun
TURKISH THORACIC JOURNAL, 2020, 21 (06): : 457 - 460
[46] Pulmonary toxicity induced by bleomycin in a patient with Hodgkin lymphoma
CF Oliveira
GA Costa
DSF Oliveira
EJ Troster
FAC Vaz
Critical Care, 9 (Suppl 2):
[47] INCREASED PULMONARY TOXICITY WITH BLEOMYCIN AND CISPLATIN CHEMOTHERAPY COMBINATIONS
RABINOWITS, M
SOUHAMI, L
GIL, RA
ANDRADE, CAV
PAIVA, HC
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (02): : 132 - 138
[48] MULTIPLE PULMONARY NODULES - UNUSUAL MANIFESTATION OF BLEOMYCIN TOXICITY
GLASIER, CM
SIEGEL, MJ
AMERICAN JOURNAL OF ROENTGENOLOGY, 1981, 137 (01) : 155 - 156
[49] SUCCESSFUL TREATMENT OF BLEOMYCIN INDUCED PULMONARY TOXICITY WITH STEROIDS
Vyas, Priyanka Ashish
Akintomi, Olugbodi
Donato, Anthony
JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S372 - S372
[50] MODIFICATION OF PULMONARY OXYGEN-TOXICITY BY BLEOMYCIN TREATMENT
MATALON, S
HARPER, WV
GOLDINGER, JM
NICKERSON, PA
OLSZOWKA, J
JOURNAL OF APPLIED PHYSIOLOGY, 1985, 58 (06) : 1802 - 1809

← 1 2 3 4 5 →